• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    VivoPower Receives Nasdaq Approval of Ticker "TEMB" for Planned Tembo Listing at a Targeted Valuation of $838 Million

    3/26/26 9:10:00 AM ET
    $VIVO
    Power Generation
    Utilities
    Get the next $VIVO alert in real time by email

    Ticker approval marks a key regulatory milestone for the listing of the business combination between VivoPower's subsidiary Tembo e-LV, and Cactus Acquisition Corporation I (CCTS)

    Tembo has previously announced securing of strategic long term investment capital from the Emirates and hence no structured PIPE capital will be required

    VivoPower expects to retain a significant equity interest in Tembo following completion of the business combination and separate listing of Tembo

    LONDON, March 26, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a leading B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, today announced that Nasdaq has approved the reservation of the ticker symbol "TEMB" for Tembo Group N.V ("Tembo Group"), the combined entity to be formed following the business combination between VivoPower's wholly-owned subsidiary, Tembo e-LV B.V. ("Tembo e-LV"), and Cactus Acquisition Corporation I (OTC:CCTSF) ("CCTS").

    This ticker approval represents a significant regulatory milestone in the progression of the business combination and proposed listing. Upon completion, Tembo Group will have its ordinary shares and public warrants listed on Nasdaq under the ticker symbols "TEMB" and "TEMBW", respectively.

    Upon completion of the business combination, VivoPower expects to retain a significant equity interest in Tembo Group N.V., subject to final transaction mechanics, including CCTS redemptions and other closing conditions. The business combination values Tembo at a pre-money indicative equity value of approximately US$838 million.

    Transaction Status and Next Steps

    The transaction is subject to a number of final closing conditions, including:

    • The Registration Statement on Form F-4 being declared effective by the U.S. Securities and Exchange Commission (SEC);
    • Confirmation of CCTS shareholder approval; and
    • Other customary conditions.

    The parties continue to work toward completion of the transaction as soon as practicable and will provide further updates as appropriate.

    As previously announced, Tembo has previously secured long term strategic investment capital from the Emirates and no structured PIPE capital is required and will not be considered. The proposed listing of Tembo as a separately traded public company is intended to unlock value for VivoPower shareholders while enabling Tembo to access growth capital directly.

    This announcement does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No assurance can be given that the business combination will be completed or that Tembo Group's securities will be listed on Nasdaq.

    About Tembo

    Tembo electric utility vehicles (EUVs) are a 100% electric solution for ruggedized and/or customized applications for fleet owners in the mining, agriculture, energy utilities, defense, police, construction, infrastructure, government, humanitarian, and game safari industries. Tembo provides safe, high-performance off-road and on-road electric utility vehicles. Its core purpose is to provide safe and reliable electrification solutions for utility vehicle fleet owners, helping to perpetuate useful life, reduce costs, maximize return on assets, meet ESG goals, and seek to further the circular economy. Tembo is a subsidiary of VivoPower, a Nasdaq-listed B Corporation.

    About VivoPower

    Originally founded in 2014 and listed on Nasdaq since 2016, VivoPower is an award-winning B Corporation with a global footprint spanning the United Kingdom, Australia, North America, Europe, the Middle East, and Southeast Asia. Today, VivoPower's mission is to be the independent, trusted partner for sovereign nations that develop and operate sustainable data center infrastructure, ensuring sovereign control over power, data, and national intelligence. In doing so, VivoPower helps sovereign nations bridge the gap between their energy assets and their AI ambitions by providing the Power-to-X infrastructure necessary to build and control their own domestic intelligence hubs.

    Forward-Looking Statements

    This communication includes certain statements that may constitute "forward-looking statements" for purposes of the U.S. federal securities laws. Forward-looking statements include, but are not limited to, statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "target", "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements may include, for example, statements about the achievement of performance hurdles, or the benefits of the events or transactions described in this communication and the expected returns therefrom. These statements are based on VivoPower's management's current expectations or beliefs and are subject to risk, uncertainty, and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements herein due to changes in economic, business, competitive and/or regulatory factors, and other risks and uncertainties affecting the operation of VivoPower's business. These risks, uncertainties and contingencies include changes in business conditions, fluctuations in customer demand, changes in accounting interpretations, management of rapid growth, intensity of competition from other providers of products and services, changes in general economic conditions, geopolitical events and regulatory changes, and other factors set forth in VivoPower's filings with the United States Securities and Exchange Commission. The information set forth herein should be read in light of such risks. VivoPower is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements whether as a result of new information, future events, changes in assumptions or otherwise.

    Forward-looking statements also include, but are not limited to, statements regarding the anticipated completion of the business combination and IPO, the anticipated trading of Tembo Group securities and the projected future performance of the combined company. These forward-looking statements are based on VivoPower's, Tembo's and CCTS's current expectations and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Actual outcomes and results may differ materially from those indicated by these forward-looking statements as a result of various factors, including, among others: the inability to complete the business combination; the inability to obtain SEC effectiveness of the Registration Statement; the inability to obtain CCTS shareholder approval; the risk that the proposed transaction may not be completed in a timely manner or at all; the risk that the conditions to the closing of the proposed transaction may not be satisfied; the possibility that competing offers or acquisition proposals could be made; the inability of Tembo Group to list its securities on Nasdaq; changes in general economic and/or industry specific conditions; and other risks and uncertainties indicated from time to time in the Registration Statement, including those under "Risk Factors" therein, and in VivoPower's other filings with the SEC. You are cautioned not to place undue reliance on forward-looking statements. VivoPower assumes no obligation and does not intend to update these forward-looking statements, except as required by law

    Important Information About the Business Combination

    In connection with the business combination, the combined company has filed with the SEC a Registration Statement on Form F-4, and in accordance with customary protocol, has received comments back to which it is compiling responses to. The definitive proxy statement and other relevant documents will be mailed to shareholders of CCTS as of a record date to be established for voting on the business combination. Shareholders of CCTS and other interested persons are advised to read, when available, the preliminary proxy statement/prospectus, and amendments thereto, and the definitive proxy statement/prospectus in connection with CCTS's solicitation of proxies for its special meeting of shareholders to be held to approve the proposed business combination, because these documents will contain important information about CCTS, Tembo, VivoPower, and the proposed business combination. Shareholders will also be able to obtain copies of the Registration Statement and the proxy statement/prospectus, without charge, once available in final approved form, on the SEC's website at www.sec.gov or by directing a request to CCTS at Cactus Acquisition Corp. 1 Ltd, 4B Cedar Brook Drive, Cranbury, NJ 08512, telephone: (609) 495-2222.

    Contact 

    Shareholder Enquiries 

    [email protected] 



    Primary Logo

    Get the next $VIVO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $VIVO

    DatePrice TargetRatingAnalyst
    2/7/2022$28.00 → $30.00Buy
    HC Wainwright & Co.
    11/15/2021$27.00 → $28.00Buy
    HC Wainwright & Co.
    8/9/2021$30.00 → $27.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $VIVO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 10, 2021 - Coronavirus (COVID-19) Update: December 10, 2021

    For Immediate Release: December 10, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On December 9, 2021, the FDA updated the SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests web page to share the latest information. The update added new information about the Meridian Bioscience, Inc. Revogene SARS-CoV-2 test, inc

    12/10/21 1:56:40 PM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VivoPower Receives Nasdaq Approval of Ticker "TEMB" for Planned Tembo Listing at a Targeted Valuation of $838 Million

    Ticker approval marks a key regulatory milestone for the listing of the business combination between VivoPower's subsidiary Tembo e-LV, and Cactus Acquisition Corporation I (CCTS) Tembo has previously announced securing of strategic long term investment capital from the Emirates and hence no structured PIPE capital will be required VivoPower expects to retain a significant equity interest in Tembo following completion of the business combination and separate listing of Tembo LONDON, March 26, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a leading B Corp-certified global developer and owner of powered land and data center infrastructure for AI com

    3/26/26 9:10:00 AM ET
    $VIVO
    Power Generation
    Utilities

    VivoPower Commences Strategic Share Conversion Program; Initial 2.96 Million Listed Class A Ordinary Shares Becoming Unlisted Restricted Class B Shares, Reducing Public Float

    Follows recently announced share acquisitions totaling 2.65 million shares by board members, including Executive Chairman and CEO, Kevin Chin, who purchased the majority of shares  Conversion program is aligned with VivoPower's broader capital strategy to minimize dilution following the recent cancellation of the Company's ATM and F-3 registration statement Strategic intent is to further align with shareholder interest, given that unlisted restricted Class B shares are non-tradeable with enhanced voting rights LONDON, March 20, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a B Corp-certified global developer and owner of powered land and data cent

    3/20/26 9:32:13 AM ET
    $VIVO
    Power Generation
    Utilities

    VivoPower Terminates $180 Million F-3 Registration Statement

    Decision reflects commitment to a strategy of non dilutive funding Alternative potential capital sources available at project level LONDON, March 18, 2026 (GLOBE NEWSWIRE) -- VivoPower PLC (NASDAQ:VIVO) ("VivoPower" or the "Company"), a leading B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, today announced that it has formally terminated its Form F-3 registration statement, originally dated December 23, 2025 (the "F-3 Registration Statement"). Effective immediately, the F-3 Registration Statement is no longer available to the Company, and no further sales of ordinary shares will be made pursuant to that filing. Th

    3/18/26 9:00:00 AM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    HC Wainwright & Co. reiterated coverage on Meridian Bioscience with a new price target

    HC Wainwright & Co. reiterated coverage of Meridian Bioscience with a rating of Buy and set a new price target of $30.00 from $28.00 previously

    2/7/22 6:13:53 AM ET
    $VIVO
    Power Generation
    Utilities

    HC Wainwright & Co. reiterated coverage on Meridian Bioscience with a new price target

    HC Wainwright & Co. reiterated coverage of Meridian Bioscience with a rating of Buy and set a new price target of $28.00 from $27.00 previously

    11/15/21 6:32:31 AM ET
    $VIVO
    Power Generation
    Utilities

    HC Wainwright & Co. reiterated coverage on Meridian Bioscience with a new price target

    HC Wainwright & Co. reiterated coverage of Meridian Bioscience with a rating of Buy and set a new price target of $27.00 from $30.00 previously

    8/9/21 6:33:26 AM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Williams Felicia returned 10,274 shares to the company, closing all direct ownership in the company

    4 - MERIDIAN BIOSCIENCE INC (0000794172) (Issuer)

    1/31/23 2:22:23 PM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form 4: Sazdanoff Catherine returned 16,424 shares to the company, closing all direct ownership in the company

    4 - MERIDIAN BIOSCIENCE INC (0000794172) (Issuer)

    1/31/23 2:21:33 PM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form 4: Rice John Mccune Jr. returned 27,449 shares to the company, closing all direct ownership in the company

    4 - MERIDIAN BIOSCIENCE INC (0000794172) (Issuer)

    1/31/23 2:20:26 PM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    SEC Filings

    View All

    SEC Form 15-12G filed by Meridian Bioscience Inc.

    15-12G - MERIDIAN BIOSCIENCE INC (0000794172) (Filer)

    2/13/23 4:31:51 PM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form 10-Q filed by Meridian Bioscience Inc.

    10-Q - MERIDIAN BIOSCIENCE INC (0000794172) (Filer)

    2/9/23 8:23:24 AM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form EFFECT filed by Meridian Bioscience Inc.

    EFFECT - MERIDIAN BIOSCIENCE INC (0000794172) (Filer)

    2/6/23 12:15:16 AM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    Leadership Updates

    Live Leadership Updates

    View All

    Meridian Bioscience Announces Retirement of CFO Bryan Baldasare

    CINCINNATI, Dec. 2, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that Bryan Baldasare, Executive Vice President, Chief Financial Officer, and Secretary, will retire from Meridian effective December 31, 2021.  The Company is engaging an executive search firm in the recruitment of a new chief financial officer.  The Company appointed Julie Smith to the position of Senior Vice President, Controller, effective December 6, 2021, and principal accounting officer, effective January 1, 2022.

    12/2/21 8:00:00 AM ET
    $VIVO
    Power Generation
    Utilities

    Meridian Bioscience Announces Retirement of Chairman David Phillips

    CINCINNATI, Nov. 24, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that David Phillips, Chairman of the Board of Directors, will retire from the Board of Directors and not seek re-election when his term ends in January 2022.  The Board of Directors will elect a new chair when Mr. Phillips' term expires and will not replace the vacated seat, which will reduce the number of directors to eight. Mr. Phillips joined the Meridian Board of Directors in 2000 and ha

    11/24/21 9:05:00 AM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    Financials

    Live finance-specific insights

    View All

    Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash Transaction

    Shareholders to Receive $34.00 Per Share in Cash, Providing Immediate, Compelling and Certain Value Transaction Follows Deliberate Review, Including Outreach to Potential Strategic and Financial Partners CINCINNATI and SEOUL, South Korea, July 7, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. ("Meridian" or the "Company") (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, and SD Biosensor, Inc. ("SDB") (KOSE: A137310) and SJL Partners LLC ("SJL") (collectively, the "Consortium") announced today that they have entered into a definitive merger agreement whereby a newly formed affiliate vehicle of the Consortium will acquire Meridian in an a

    7/7/22 7:17:00 AM ET
    $VIVO
    Power Generation
    Utilities

    MERIDIAN BIOSCIENCE REPORTS RECORD SECOND QUARTER FISCAL 2022 OPERATING RESULTS

    CINCINNATI, May 6, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced financial results for the second quarter ended March 31, 2022. Second Quarter Fiscal 2022 Highlights (Comparison to Second Quarter Fiscal 2021): Consolidated net revenues totaled $111.2 million, the highest in Company history, with both segments ahead of expectationsLife Science segment delivered record net revenues of $70.1 millionDiagnostics segment net revenues increased 29% year-over-year to a record $41.1 millionLaunched Lyo-Ready™ sample specific master mixes for bloodResumed

    5/6/22 8:00:00 AM ET
    $VIVO
    Power Generation
    Utilities

    Meridian Acquires EUPROTEIN to Further Expand Recombinant Protein Capabilities

    CINCINNATI, Ohio, May 2, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has acquired, through its subsidiary Meridian Life Science, Inc., substantially all of the assets of EUPROTEIN Inc.  The transaction closed on April 30, 2022. EUPROTEIN Inc. offers custom development and production of high-quality bioresearch reagents, with a particular focus on human and other mammalian proteins and recombinant monoclonal antibodies.  This acquisition will help

    5/2/22 8:47:00 AM ET
    $VIVO
    Power Generation
    Utilities

    $VIVO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Meridian Bioscience Inc. (Amendment)

    SC 13G/A - MERIDIAN BIOSCIENCE INC (0000794172) (Subject)

    2/9/23 11:27:43 AM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form SC 13D/A filed by Meridian Bioscience Inc. (Amendment)

    SC 13D/A - MERIDIAN BIOSCIENCE INC (0000794172) (Subject)

    2/3/23 2:06:19 PM ET
    $VIVO
    Power Generation
    Utilities

    SEC Form SC 13G/A filed by Meridian Bioscience Inc. (Amendment)

    SC 13G/A - MERIDIAN BIOSCIENCE INC (0000794172) (Subject)

    1/31/23 11:06:04 AM ET
    $VIVO
    Power Generation
    Utilities